Navigation Links
FDA Updates Prescription Guidelines for Blood Thinner
Date:8/18/2007

Gene variations dictate how quickly a patient metabolizes warfarin, officials say

THURSDAY, Aug. 16 (HealthDay News) -- The U.S. Food and Drug Administration announced Thursday a labeling update for the widely prescribed blood thinner warfarin (Coumadin), advising doctors that patients' genetic makeup can affect how they respond to the drug.

Responses to warfarin depend on a patient's variants of the genes CYP2C9 and VKORC1. About 30 percent of patients -- many of them heart patients -- who take warfarin have these gene variants.

These variations can determine how fast warfarin is metabolized, Larry Lesko, director of the FDA's office of clinical pharmacology at the Center for Drug Evaluation and Research, said during a teleconference. "Patients with these variations may need lower doses of warfarin than patients with the usual forms of these genes.

"The label change explains that certain people are likely to respond very differently to the drug if they happen to carry variations of two of their genes," Lesko said. The label updates are based on recent studies that found patients' response to the drug depends on these gene variations, he added.

In the United States, some 2 million people start taking warfarin every year to prevent blood clots, heart attacks and stroke, according to the FDA. Warfarin is tricky to use, because the correct dose varies and depends on risk factors, including diet, age, and other medications the patient is taking.

If the warfarin dose is too high, there is the risk of life-threatening bleeding. If the dose is too low, there is a risk of developing blood clots. Dosing is particularly important when starting the drug, the FDA said.

The FDA isn't mandating that doctors obtain genetic tests before prescribing warfarin but suggests that it is something doctors may want to consider when prescribing the drug.

"Doctors and other health-care professio
'/>"/>


Copyright©2007 ScoutNews,LLC.

Page: 1 2 3

Related medicine news :

1. WHO Updates Outdated Pediatric Growth Charts
2. A prescription cream for unwanted facial hair
3. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
4. Prescription Drug - Helps People Stop Smoking
5. Misleading Advertisements for Prescription Drugs
6. Patients Pressure Would Result In Overprescription
7. TV drug commercials prompt prescriptions
8. Prescription Drug Use Varies Widely Between States
9. Status of some prescription drugs
10. Abuse of prescription drugs among youths on the rise
11. Does Your Prescription Have An Inappropriate Medicine?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Enthusiasts of gourmet cuisine and beverages will ... 2015. The event will be held in the heart of ... Ave NW, Grand Rapids, MI 49503) and will feature wine ... Patrons are encouraged to savor the food and beverage pairings ... year’s event will feature seven chefs, including:, ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
(Date:4/17/2015)... 17, 2015 Calvary Hospital recently announced Timothy ... Executive Vice President on May 11. The Fund directs all ... mission. Barr succeeds Vincent J. Spinelli, who retired several months ... take on and supervise the important work that the Fund ... “As Calvary continues to expand and bring our signature care ...
(Date:4/17/2015)... Nomedexamlifeinsurance.com has released a new blog post explaining how ... , Smoking is linked to numerous diseases like cancer ... smokers more money for life insurance plans. Someone who ... can qualify for advantageous offers. , The life ... non-smokers. Comparing quotes is the best method of reducing ...
(Date:4/17/2015)... Verndale, a Global Experience Technology Company, ... been chosen as a Boston Business Journal (BBJ) Pacesetter, ... the region. The BBJ’s Pacesetters represents privately held businesses ... 2014. This is the eighth consecutive year and the ... has been honored with this award. , “Being honored ...
Breaking Medicine News(10 mins):Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 2Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 3Health News:Life Insurance Quotes for Smokers Available Online 2Health News:Verndale Honored as 2015 Boston Business Journal Pacesetter, Named 46th Fastest Growing Private Company 2
... BioFit Engineered Products, an Ohio-based manufacturer and long-standing leader in ... and Atmospheric Administration (NOAA) with a solution to a unique ... habitat. , ... Bowling Green, OH ...
... expansion of its Sealy office. , ... Sealy, Texas (PRWEB) January 8, ... Sealy office. Located on Meyer Street the five-year old-practice has blossomed reaching ... of the surrounding communities as well., , , , ,The eye ...
... Service Employees,International Union (SEIU) announced the formation of the ... the patients that they serve,a greater voice as we ... nation,s,history. , Since adoption of ... made,numerous jurisdiction decisions that have helped members who do ...
... Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" ... and personal care products company announced that on January ... stock repurchase fund according to the terms approved by ... up to Ps. 100 million pesos. Company Description ...
... EXTON, Pa., Jan. 9 Kensey Nash Corporation (Nasdaq: ... release its earnings results for its second quarter ended ... Wednesday, January 28, 2009. Joe Kaufmann, President and ... results on Wednesday, January 28, 2009 at 9:00 A.M. ...
... study found, , , FRIDAY, Jan. 9 (HealthDay News) -- If ... cut your risk of dying from flu in half, research ... perfect match for the strains circulating in any given year, ... that included 10 flu seasons, worth of data also found ...
Cached Medicine News:Health News:BioFit 1Y Takes the Plunge to Fill Undersea Seating Role for NOAA 2Health News:Austin County Eye Expands Sealy Eye Clinic Office 2Health News:Statement From SEIU International President Andy Stern on UHW Leaders' Response to the Jurisdiction Decision 2Health News:Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference 2Health News:You're Never Too Old for a Flu Shot 2Health News:You're Never Too Old for a Flu Shot 3
(Date:4/17/2015)... -- CVS Health Corporation (NYSE: CVS ) will ... 2015, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will be ... CVS Health website for all interested parties. To access ... be archived and available on the web site for ...
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ) has ... Global Strategic Business Report" report to their offering. ... ADME-Toxicology Testing in US$ Million by the following Segments: ... The report provides separate comprehensive analytics for the ... , Europe , ...
(Date:4/17/2015)... 2015  Trovagene, Inc., (NASDAQ:  TROV) a developer ... data presented at the 2015 European Lung Cancer ... Monitoring ℠ (PCM) platform outperformed tissue biopsy ... T790M mutations in metastatic lung cancer patients. ... Mutation in Urinary Circulating Tumor DNA from Metastatic ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 2Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 3Trovagene's Urinary ctDNA Assay Outperforms Tissue Biopsy in Clinical Study for the Detection of EGFR T790M Mutations in Metastatic Lung Cancer Patients 4
... Mass., Nov. 24 Echo Therapeutics, Inc. (OTC Bulletin ... System as a non-invasive, wireless, transdermal continuous glucose monitoring ... drug delivery, announced today that Patrick T. Mooney, M.D., ... 13th Annual Biotech and Specialty Pharmaceuticals Conference, sponsored by ...
... , NORTH HOLLYWOOD, Calif., Nov. 24 IPC The Hospitalist Company, ... practice company, announced today that Philip Vaidyan, M.D., FACP, an IPC ... the 2009 Top Ten Hospitalists in the nation. He was recognized ... has been a practicing physician for more than 10 years and ...
Cached Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: